Benzinga | Apr 29, 2021 05:06PM EDT

Bio-Rad Laboratories Q1 EPS $5.21 Beats $3.00 Estimate, Sales $726.80M Beat $660.98M Estimate

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $5.21 per share which beat the analyst consensus estimate of $3.00 by 73.67 percent. This is a 172.77 percent increase over earnings of $1.91 per share from the same period last year. The company reported quarterly sales of $726.80 million which beat the analyst consensus estimate of $660.98 million by 9.96 percent. This is a 27.14 percent increase over sales of $571.64 million the same period last year.